CAS: 15905-32-5; 3',6'-Dihydroxy-2',4',5',7'-Tetraiodo-3H-Spiro[isobenzofuran-1,9'-Xanthen]-3-One

该化合物是荧光素家族的合成有机化合物,其特点是荧光素系,其特点是:一种有4个碘原子核心,其4个原子替换为2欧元,4欧元,5欧元和7欧元,与非碘化氟化素衍生物相比,其光学特性大为改变;碘的存在增强了其亲脂性,并可能影响其在不同溶剂中的溶解性;四硫化素主要用作生物和化学应用中的荧光染色剂,包括微镜和流动细胞测量;此外,它可以作为环境研究的追踪器,并有可能在光动能疗法中应用;其化学结构有助于其独特的光谱特性,使其在研究与诊断领域具有价值;然而,处理应谨慎处理,同时考虑到卤化化合物的潜在毒性.

结构式图片

欧盟法规

ECHA物质ECHA物质化妆品禁用物质清单C&L通报REACH预注册

上下游产品

ethanol fluorescein2',4',5',7'-tetraiodofluorescein disodium salt

合成工艺路线路线简述

  • 合成目标产物 Erythrosin B 主要起始原料 Fluorescein
  • (文献来源)合成步骤主要原料 Fluorescein
荧光素置于双氧水,Sodium Iodide体系中,用 乙醇 用作溶剂,化学反应 5.0H,反应生成藻红b
参考文献:一种制备四碘荧光素b的工艺方法
标题:一种制备四碘荧光素b的工艺方法
摘要:本发明公开了一种制备四碘荧光素b的工艺方法,包括如下步骤:步骤一,以荧光素为初始原料,在溶剂和催化剂的作用下,与碘盐反应制得四碘荧光素;步骤二,将步骤一中制备的四碘荧光素在溶剂作用下,与碱反应制得四碘荧光素b.本发明具有以下有益效果:操作简便,成本低,收率高,污染小,碘元素利用率高,适于工业化生产,并能够适合多数相关企业进行生产.

海关参考信息

专利信息


专利号:US-2024287520-A1
优先权日:2021-06-30
标题:Method for synthesis of linkage modified oligomeric compounds
发明人:RODRIGUEZ ANDREW A
权利人:IONIS PHARMACEUTICALS INC
摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:WO-2004011474-A1
优先权日:2002-07-31
标题:Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-6653468-B1
优先权日:2002-07-31
标 题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
权利人:ISIS PHARMACEUTICALS INC
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-9365607-B1
优先权日:2012-07-31
标题 :Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides
发明人:SRIVASTAVA SURESH C; YASKO AMY
权利人:ASED LLC
摘要:The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.

专利号:US-2025171493-A1
优先权日:2022-03-05
标题 :Processes for synthesis of withanolides and withaferins and analogs thereof
发明人:LOPCHUK JUSTIN MATTHEW
权利人:H LEE MOFFITT CANCER CT & RES
摘要:The present disclosure provides processes for the synthesis of withanolides such as Withanolide A and Withanolide D.
洛阳市太学染化有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chinataixue.com
电话: 0379-69828658👤
📞洛阳市太学染化有限公司 ⚠️参考联系方式

销售电话:0379-69828658
邮箱:sales@chinataixue.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1016/j.ijpharm.2011.07.005
摘要:Al-Kattan A, Girod-Fullana S, Charvillat C, Ternet-Fontebasso H, Dufour P, Dexpert-Ghys J, Santran V, Bordère J, Pipy B, Bernad J, Drouet C. Biomimetic nanocrystalline apatites: Emerging perspectives in cancer diagnosis and treatment. International Journal of Pharmaceutics. 2012 Feb;423(1):26–36. doi: 10.1016/j.ijpharm.2011.07.005.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知